Cannabidiol (CBD) for the treatment of bipolar affective disorder (2007)
- Authors:
- USP affiliated authors: CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; QUEIROZ, REGINA HELENA COSTA - FCFRP ; ZUARDI, ANTONIO WALDO - FMRP
- Unidades: FMRP; FCFRP
- Subjects: TRANSTORNO BIPOLAR; CANNABIS
- Language: Inglês
- Imprenta:
- Publisher: International Cannabinoid Research Society
- Publisher place: Québec
- Date published: 2007
- Source:
- Título: Program and Abstracts
- Conference titles: Annual Symposium on the Cannabinoids
-
ABNT
CRIPPA, José Alexandre de Souza et al. Cannabidiol (CBD) for the treatment of bipolar affective disorder. 2007, Anais.. Québec: International Cannabinoid Research Society, 2007. . Acesso em: 29 abr. 2025. -
APA
Crippa, J. A. de S., Hallak, J. E. C., Vilela, J. A. A., Morais, S. L., Sanches, R. F., Malfará, W., et al. (2007). Cannabidiol (CBD) for the treatment of bipolar affective disorder. In Program and Abstracts. Québec: International Cannabinoid Research Society. -
NLM
Crippa JA de S, Hallak JEC, Vilela JAA, Morais SL, Sanches RF, Malfará W, Camargo SPS, Musty RE, Queiroz RHC, Zuardi AW. Cannabidiol (CBD) for the treatment of bipolar affective disorder. Program and Abstracts. 2007 ;[citado 2025 abr. 29 ] -
Vancouver
Crippa JA de S, Hallak JEC, Vilela JAA, Morais SL, Sanches RF, Malfará W, Camargo SPS, Musty RE, Queiroz RHC, Zuardi AW. Cannabidiol (CBD) for the treatment of bipolar affective disorder. Program and Abstracts. 2007 ;[citado 2025 abr. 29 ] - Safety and side effects of cannabidiol, a Cannabis sativa constituent
- Olanzapine, weight change and metabolic effects: a naturalistic 12-month follow up
- Cannabidiol: an anxiolytic or an antipsychotic new drug?
- Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study
- Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizopherenia: an update
- Development and validation of a liquid-liquid extraction and gas chromatography/mass spectrometry methodology for cannabidiol analysis in human plasma
- Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report
- Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
